Phase
Condition
Congestive Heart Failure
Dermatomyositis (Connective Tissue Disease)
Cardiomyopathy
Treatment
characterization of a large national cohort of patients with suspected myocarditis or inflammatory cardiomyopathy.
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
• Presence of at least one compatible symptom and at least one objective finding in diagnostic tests (Figure 2), according to the consensus document of the European Society of Cardiology (1):
A. Clinical presentation:
Acute chest pain: pericardial or pseudo-ischemic.
Dyspnea on exertion or at rest for up to 3 months.
Dyspnea on exertion or at rest for 3 months - 1 year.
Unexplained palpitations / arrhythmias, sudden death recovered.
Unexplained cardiogenic shock.
B. Findings in complementary tests:
ECG: new onset AV block, new onset bundle branch block, ST segment elevation/depression, T wave inversion
Elevation of TnI/TnT
Segmental or global contractility alterations not explained by other causes
Positive Lake Louise criteria in cardiac MRI (13) (Annex III Figure S1) • Patients who have given their informed consent.
Study Design
Study Description
Connect with a study center
HCUVA
Murcia, 30120
SpainActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.